Exhibit 107

Calculation of Filing Fee Tables

FORM S-1

(Form Type)

BRIACELL THERAPEUTICS CORP.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation Rule		Amount Registered	Proposed Maximum Offering Price Per Share	Maximum Aggregate Offering Price(1)(2)			Fee Rate		Amount of Registration Fee
Fees to Be Paid	Equity	Common Units (2)		457(o)			$	2,300,000	(3)	$	0.00015310	$	352.13
Fees to Be Paid	Equity	Common shares, no par value, included in the Common Units						-	(4)
Fees to Be Paid	Equity	Warrants included in the Common Units						-	(4)
Fees to Be Paid	Equity	Pre-funded Units (5)						-	(3)
Fees to Be Paid	Equity	Pre-funded Warrants included in the Pre-funded Units						-	(6)
Fees to Be Paid	Equity	Common shares underlying the Pre-funded warrants included in the Pre-funded Units
Fees to Be Paid	Equity	Common shares underlying the warrants included in the Common Units and the Pre-funded Units					$	2,875,000		$	0.00015310	$	440.16
Fees to Be Paid	Equity	Warrants to be issued to the Underwriters						-	(7)
Fees to Be Paid	Equity	Common shares underlying warrants to be issued to the Underwriters					$	143,750	(7)	$	0.00015310	$	22.01
	Total Offering Amounts						$	5,318,750				$	814.30
	Total Fees Previously Paid											$	-
	Total Fee Offsets											$	-
	Net Fee Due											$	814.30

(1)	Represents only the additional dollar amount of securities being registered and includes the additional dollar amount of securities that the underwriters have the option to purchase to cover over-allotments, if any. Does not include the securities that the registrant previously registered on the registration statement on Form S-1 (File No. 333-286670).
(2)	Each Common Unit consists of one common share and one warrant, each whole warrant exercisable for one common share.
(3)	The proposed maximum aggregate offering price of Common Units proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-funded Units offered and sold in the offering, and the proposed maximum aggregate offering price of the Pre-funded Units to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Units sold in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Units and Pre-funded Units (including the common shares issuable upon exercise of the Pre-funded warrants included in the Pre-funded Units), if any, is $2,300,000.
(4)	Included in the price of the Common Units. No separate registration fee required pursuant to Rule 457(g) under the Securities Act of 1933, as amended.
(5)	Each Pre-funded Unit consists of one Pre-funded warrant to purchase one common share and one warrant to purchase one common share.
(6)	Included in the price of the Pre-funded Units. No separate registration fee required pursuant to Rule 457(g) under the Securities Act of 1933, as amended.
(7)	We have agreed to issue to the underwriters warrants to purchase a number of common shares equal to 5% of the aggregate number of Common Units and Pre-funded Units sold in the offering (including the Common Units and Pre-funded Units issuable upon exercise of the over-allotment option). The warrants are exercisable at a per share exercise price equal to 125% of the per Common Unit public offering price for five years after the effective date of this registration statement.